Search

everythinglearnresearchcommunity

for

Search:↓

A user experienced skin irritation and acne while using Minoxidil foam, but after stopping both the foam and a sea salt spray, their skin improved. They plan to try oral Minoxidil, suspecting the sea salt spray, not Minoxidil, was the main cause of their skin issues.

Hair loss from seborrheic dermatitis can be temporary. Treatments discussed include Minoxidil, finasteride, and RU58841, along with collagen and biotin supplements.

The conversation is about whether stemoxydine can shorten the dormant phase after a hair transplant, known as the ugly duckling phase. There is skepticism about whether it actually works as claimed.

A 78-year-old man regrew hair after suffering burns, suggesting that injury-induced healing processes might trigger hair growth. Microneedling and other treatments like minoxidil and finasteride are discussed as potential methods to stimulate similar regrowth.

A 35-year-old man has been using a topical solution with finasteride, minoxidil, retinoic acid, and hydrocortisone for hair regrowth, experiencing minor side effects. He plans to remove hydrocortisone due to potential long-term health risks.

The conversation discusses experiences with hair loss treatments containing RootBioTec and Anagain. Users share their results and compare these treatments to Minoxidil, finasteride, and RU58841.

User considers making Zix topical solution with ethanol/alcohol for hair loss treatment. Asks if crushing b6 and zinc into stemoxydine is possible.

A 21-year-old's hair loss worsened despite using finasteride, oral and topical minoxidil, microneedling, and keto shampoo for a year. They are considering switching to dutasteride and improving their diet.

The conversation discusses hair loss struggles and treatments, including oral minoxidil, oral finasteride, and RU58841. Users share experiences and advice, suggesting options like topical minoxidil, microneedling, hair transplants, and scalp micropigmentation.

A 15-year-old experiencing severe diffuse thinning plans to use minoxidil, dermarolling, and possibly ketoconazole, with hopes to later incorporate finasteride. Concerns about starting finasteride too young and the need for a dermatologist consultation are discussed.

The user is experiencing slow but solid hair regrowth using topical finasteride, oral minoxidil, keto shampoo, microneedling, RU58841, and rosemary oil. Another user suggests being grateful for the dense coverage.

OP reported significant hair regrowth using oral minoxidil 5mg, dutasteride 0.5mg, and dermastamping. Users discussed side effects, effectiveness of treatments, and debated dermastamp needle sizes.

Clascoterone's European release is expected in Q4 2026, with FDA approval anticipated by mid-2027. The discussion includes questions about the approval timeline and potential acceleration due to unmet needs.

A 22-year-old has been using topical finasteride and minoxidil with microneedling for hair loss, considering switching to oral finasteride or dutasteride due to slowed progress. Recent changes in application technique and increased microneedling frequency seem to have led to noticeable hair regrowth, prompting reconsideration of switching treatments.

The user experienced noticeable hairline regrowth after starting finasteride for crown hair loss, despite scalp irritation from topical minoxidil. They are impatient for crown results.

The user shared their 10-year hair loss journey, discussing treatments like oral minoxidil, oral finasteride, and LLLT, and ultimately deciding on a hair transplant. They also explored the possibility of having alopecia areata incognita and advised seeking multiple opinions before surgery.

A 21-year-old male with a thyroid condition noticed his hair thinning uniformly without a receding hairline. He is considering using a 5ARI to prevent further baldness if he starts TRT.

The user has been using finasteride and minoxidil for nearly three years, maintaining and possibly regrowing hair despite noticing shedding and miniaturized hairs. They are considering adding another treatment due to concerns about ongoing hair loss.

Stemoxydine may work synergistically with minoxidil and finasteride for hair growth, but its effectiveness is debated, with some users experiencing minimal results and concerns about cost. Users suggest sticking to proven treatments like minoxidil and finasteride, while considering stemoxydine as an additional option.

3aHSD enzyme's role in hair loss and a crowdfund for research. Goal: explore new treatments, study RU58841, and develop natural topical product.

A user who has tried multiple treatments for hair loss, including oral and topical finasteride and liposomal finasteride, but experienced severe side effects in each case; the user is considering trying RU58841 or aromatise inhibitors as alternatives.

OP shared progress pictures 8 months after FUE surgery in Korea by Dr. Hyun, using Dutasteride. Users discussed the use of Dutasteride over Finasteride in Korea.

A 38-year-old user discusses their experience with hair loss and the impact of comments about their bald spot, despite using treatments like topical finasteride, minoxidil, and tretinoin. The conversation highlights the emotional impact of unsolicited comments on appearance and suggests exploring additional treatments like oral minoxidil and finasteride for further improvement.

OP is concerned about hairline recession and was advised by dermatologists to use Minoxidil on the hairline, despite doubts about its effectiveness there. OP is unsure about not being prescribed Finasteride and is considering whether to seek it independently.

Pelage is developing a topical hair follicle stem cell therapy, PP405, for non-scarring alopecias like androgenetic alopecia, with Phase III trials planned and a potential market launch by 2027. The treatment may not require continuous use after initial regrowth.

The conversation discusses using oral minoxidil and finasteride for hair regrowth, with the addition of vitamins. Users report some shedding and expect results in 3-6 months.

RU58841, an anti-androgenic compound, showed early promise for treating alopecia but faced challenges after its patent in 1997. Despite advancing to Phase II trials, safety concerns and financial struggles led Aventis to abandon its development. Proskelia, which later merged into ProStrakan, couldn't prioritize the drug, leading to its eventual stagnation and failure to reach the market.

The user stabilized hair loss with oral Finasteride and saw significant hair growth after adding oral Minoxidil. They also used collagen peptides and had no side effects.

The user is using 1mg oral finasteride daily, applying topical minoxidil 1-2 times daily, and using Nizoral shampoo twice a week for hair regrowth. They are discussing their progress at month 13 of this treatment regimen.